Sign in to view content

Real World Experience of Brolucizumab for Persistent Macular Fluid in Neovascular Age-Related Macular Degeneration After Prior Anti-VEGF Treatments

Rehan M. Hussain, MD

Video
Published 2021

Related

Brolucizumab for the Treatment of Visual Impairment Due to Diabetic Macular Edema: 52-Week Results From the KESTREL and KITE Studies
David M. Brown, MD
Annual Meeting Talks
2021
Modifier-25 Examinations Reduce Travel Burden, Decrease Treatment Cost, and Improve QALY for Exudative Age-Related Macular Degeneration Patients
Henry A Leder, MD
Annual Meeting Talks
2020
Current United States Treatment Patterns for the Treatment of Proliferative Diabetic Retinopathy in the IRIS Registry
Jeremiah Brown, MD, MS, FASRS
Annual Meeting Talks
2020

Category: AMD - Neovascular

See more